Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. (Q34418281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. |
scientific article |
Statements
1 reference
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. (English)
1 reference
C D Bloomfield
1 reference
J C Byrd
1 reference
R B Weiss
1 reference
D C Arthur
1 reference
D Lawrence
1 reference
M R Baer
1 reference
F Davey
1 reference
E S Trikha
1 reference
A J Carroll
1 reference
R Tantravahi
1 reference
M Qumsiyeh
1 reference
S R Patil
1 reference
J O Moore
1 reference
R J Mayer
1 reference
C A Schiffer
1 reference
1 February 1997
1 reference
1 reference
15
1 reference
466-475
1 reference
Identifiers
1 reference
1 reference